KIT K642E
|
Cutaneous Melanoma
|
KIT K642E
|
Cutaneous Melanoma
|
imatinib Sensitive: A2 - Guideline
|
imatinib Sensitive: A2 - Guideline
|
KIT K642E
|
Melanoma
|
KIT K642E
|
Melanoma
|
imatinib Sensitive: C3 – Early Trials
|
imatinib Sensitive: C3 – Early Trials
|
KIT K642E
|
Melanoma
|
KIT K642E
|
Melanoma
|
temozolomide Resistant: C4 – Case Studies
|
temozolomide Resistant: C4 – Case Studies
|
KIT K642E
|
Melanoma
|
KIT K642E
|
Melanoma
|
dasatinib Sensitive: C4 – Case Studies
|
dasatinib Sensitive: C4 – Case Studies
|